Clearance Summary
MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM received FDA 510(k) clearance under submission number K100559, sponsored by Interlace Medical, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Obstetrics/Gynecology review panel. The statutory decision date of record is 2010-03-30.
- Submission: K100559
- Applicant / Sponsor: Interlace Medical, Inc.
- Clearance pathway: Special
- Review panel: Obstetrics/Gynecology
- Device class: Class II
- Regulation citation: 21 CFR 884.1690
- Decision date: 2010-03-30
Classification & Regulation
This clearance is catalogued under FDA product code HIH and 21 CFR 884.1690, within the Obstetrics/Gynecology review panel as a Class II device.